Metraipolis › archive › dc_d7e7bddda0dc
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke — Europe PMC PMID:42048077
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42048077
- DOI
- 10.1001/jamanetworkopen.2026.9584
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:10:34.646Z
- SHA-256 of the archived text
d87d346c652c839f5c033202af5038991007de19dbd32403cc8cf9fc7d107008- Stable URL of this page
https://metraipolis.com/documento/dc_d7e7bddda0dc
How to cite
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke — Europe PMC PMID:42048077 — Europe PMC (en), https://europepmc.org/article/MED/42048077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7e7bddda0dc (Metraipolis archive dc_d7e7bddda0dc, sha256 d87d346c652c839f5c033202af5038991007de19dbd32403cc8cf9fc7d107008)
BibTeX
@misc{dcd7e7bddda0dc,
title = {Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke — Europe PMC PMID:42048077},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42048077},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7e7bddda0dc; sha256 d87d346c652c839f5c033202af5038991007de19dbd32403cc8cf9fc7d107008},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42048077. Agents can read the archived copy with the MCP tool read_document.